IEX IDEX CORP /DE/ Insider Trading

CEO Eric Ashleman exercised stock options and immediately sold all shares, netting $3.3M with stock near 52-week highs.

CEO and President Eric Ashleman exercised approximately 15,000 shares and immediately sold them all on the same day, realizing gross proceeds of over $3.3 million. The transactions consist of acquiring shares through option exercise at substantially below-market prices, then liquidating the entire position at prices near the stock's current level. This is Ashleman's first open-market activity of any kind in the past three years—prior filings show only stock-based compensation transactions. The stock is trading slightly below its 52-week high, and the company itself is profitable with growing revenue, making this a liquidation rather than a forced sale during distress. What's notable is the mechanical pattern: acquire and immediately divest on the same day shows no net conviction in holding the shares after exercise, a common tax-planning approach for executives exercising compensation rather than an operational insider sentiment.

Director Carl R Christenson bought 600 IEX shares at $169.41; now holds 6.4K shares (+10.4%)

Director Carl R Christenson purchased 600 shares of IDEX CORP /DE/ at $169.41 on 2025-11-05, increasing his holdings to 6,351 shares. The transaction occurred at a price $1.45 above the current market price of $167.96, and within the 52-week range of $157.53–$236.06. The stock is currently trading 28.8% below its 52-week high. With the company reporting net income of $127.8M on quarterly revenue of $878.7M and a P/E of 26.28, the fundamentals show stability, though annual revenue growth is flat at -0.2%. The purchase adds to the director's stake but represents routine insider activity without extraordinary concentration or pattern signals.

Director Helmkamp buys 2,500 shares of IDEX at $159.61; holds 13,200 shares post-transaction as stock down 33.3% from 52-week high.

Helmkamp Katrina L, a director of IDEX CORP, purchased 2,500 shares at $159.61 on 2025-08-07, increasing her total holdings to 13,200 shares from 10,700 shares. The purchase occurred while IDEX stock trades at $157.53, down 33.3% from its 52-week high of $236.06 and down 13.2% over the prior 30 days. The company reports a P/E of 25.29 with annual revenue growth of -0.2%, indicating a mature profile with modest valuation metrics. This director-level acquisition occurs in a context of recent stock weakness, though the company maintains substantial profitability with $131.6M in net income on $865.4M quarterly revenue.